Therapeutic Specialties Archives

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

Certara2025年10月31日

Case Study

サターラとDizal 、肺がん治療薬スンボゼルチニブのFDA承認を迅速化すべく提携

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

Certara2025年10月2日

Conference

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Certara2025年9月22日

メディア掲載

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Explore the top challenges in cell & gene therapy commercialization, featuring expert insights from Fran…

Certara2025年9月12日

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Certara2025年9月4日

Case Study

Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management

Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…

Certara2025年8月18日

Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…

Certara2025年8月13日

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

Certara2025年7月31日

Press Coverage

Digital twins and virtual trials: A new era in rare disease drug development

Discover how using digital twins in rare disease drug development is improving precision and accelerating…

Certara2025年7月22日

Publication

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully…

Certara2025年6月19日

Powered by Translations.com GlobalLink Web Software

治療領域

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

サターラとDizal 、肺がん治療薬スンボゼルチニブのFDA承認を迅速化すべく提携

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Digital twins and virtual trials: A new era in rare disease drug development

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

メルマガ登録

クイックアクセス

ソリューション

お問合せ